Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lyell Immunopharma, Inc.

0.7058
+0.00220.31%
Volume:216.37K
Turnover:152.33K
Market Cap:206.21M
PE:-0.88
High:0.7210
Open:0.7162
Low:0.6900
Close:0.7036
Loading ...

Lyell Immunopharma Reports Q3 2024 Financial Results

TIPRANKS
·
08 Nov 2024

Lyell Immunopharma Q3 EPS $(0.17) Beats $(0.20) Estimate, Sales $34.00K Up From $25.00K YoY

Benzinga
·
08 Nov 2024

Lyell Immunopharma: Q3 Earnings Snapshot

Associated Press Finance
·
08 Nov 2024

Lyell Immunopharma Q3 Revenue USD 34 Thousand

THOMSON REUTERS
·
08 Nov 2024

Lyell Immunopharma : Our Strong Cash Position Enables US to Advance Our Pipeline Through Important Clinical Milestones and Fund Operations Into 2027

THOMSON REUTERS
·
08 Nov 2024

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024

GlobeNewswire
·
08 Nov 2024

Lyell Announces Presentation of Initial Clinical Data From the Phase 1-2 Clinical Trial of Impt-314 for the Treatment of B-Cell Lymphoma at the 2024 American Society of Hematology (Ash) Annual Meeting

THOMSON REUTERS
·
05 Nov 2024

Buy/Sell: Wall Street's Top 10 Stock Calls This Week

The Fly
·
03 Nov 2024

LiveOne Leads The Pack Of 3 US Penny Stocks

Simply Wall St.
·
02 Nov 2024

Lyell Immunopharma’s Strategic Moves and Leadership Expansion

TIPRANKS
·
01 Nov 2024

Lyell Immunopharma Completes Acquisition of Immpact Bio

THOMSON REUTERS
·
01 Nov 2024

Lyell Immunopharma Completes Acquisition of ImmPACT Bio

GlobeNewswire
·
01 Nov 2024

Lyell Immunopharma Shares Fall After BofA Downgrade

MT Newswires Live
·
31 Oct 2024

Lyell shares down as BofA double downgrades to Sell

Investing.com
·
30 Oct 2024

Lyell Immunopharma Inc : Bofa Global Research Cuts Price Objective to $1 From $6

THOMSON REUTERS
·
30 Oct 2024

Lyell Immunopharma Cut to Underperform From Buy by B of A Securities

Dow Jones
·
30 Oct 2024